These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 12211417

  • 1. Risperidone: a potential treatment for autism.
    Posey DJ, McDougle CJ.
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1212-6. PubMed ID: 12211417
    [Abstract] [Full Text] [Related]

  • 2. Role of risperidone in children with autism spectrum disorder.
    Chavez B, Chavez-Brown M, Rey JA.
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [Abstract] [Full Text] [Related]

  • 3. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [Abstract] [Full Text] [Related]

  • 4. The treatment of autistic children with risperidone.
    Dodig-Curković K, Curković M, Radić J, Radić M.
    Coll Antropol; 2011 Jan; 35 Suppl 1():297-301. PubMed ID: 21648351
    [Abstract] [Full Text] [Related]

  • 5. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
    McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, Freeman BJ, Martin A, McGough JJ, Cronin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, Volkmar FR, Votolato NA, Walson P.
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197
    [Abstract] [Full Text] [Related]

  • 6. Risperidone use in the treatment of behavioral symptoms in children with autism.
    West L, Waldrop J.
    Pediatr Nurs; 2006 Jan; 32(6):545-9. PubMed ID: 17256292
    [Abstract] [Full Text] [Related]

  • 7. Toward specifying pervasive developmental disorder-not otherwise specified.
    Mandy W, Charman T, Gilmour J, Skuse D.
    Autism Res; 2011 Apr; 4(2):121-31. PubMed ID: 21298812
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL.
    J Clin Psychiatry; 2005 Apr; 66 Suppl 10():26-31. PubMed ID: 16401147
    [Abstract] [Full Text] [Related]

  • 9. Psychopharmacology in autism: an update.
    Canitano R, Scandurra V.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan 15; 35(1):18-28. PubMed ID: 21034789
    [Abstract] [Full Text] [Related]

  • 10. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA, McDougle CJ.
    Child Adolesc Psychiatr Clin N Am; 2008 Oct 15; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of behavioral disorders by risperidone in children with autism].
    Wei BY, Huang F, Qin XT, Liang QQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Mar 15; 13(3):216-8. PubMed ID: 21426640
    [Abstract] [Full Text] [Related]

  • 12. Autistic spectrum disorders 2: diagnosis and management.
    Jones A, Cork C, Chowdhury U.
    Community Pract; 2006 Apr 15; 79(4):128-30. PubMed ID: 16634517
    [Abstract] [Full Text] [Related]

  • 13. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
    McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B.
    Am J Psychiatry; 2005 Jun 15; 162(6):1142-8. PubMed ID: 15930063
    [Abstract] [Full Text] [Related]

  • 14. [Sixty years of autism].
    van Berckelaer-Onnes IA.
    Ned Tijdschr Geneeskd; 2004 May 22; 148(21):1024-30. PubMed ID: 15185436
    [Abstract] [Full Text] [Related]

  • 15. [Autism spectrum disorders in adults].
    Kan CC, Buitelaar JK, van der Gaag RJ.
    Ned Tijdschr Geneeskd; 2008 Jun 14; 152(24):1365-9. PubMed ID: 18664213
    [Abstract] [Full Text] [Related]

  • 16. [Autism of unknown aetiology].
    Holguín JA.
    Rev Neurol; 2008 Jun 14; 37(3):259-66. PubMed ID: 12938058
    [Abstract] [Full Text] [Related]

  • 17. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr 14; 15(82):43-5. PubMed ID: 16602211
    [Abstract] [Full Text] [Related]

  • 18. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.
    Capone GT, Goyal P, Grados M, Smith B, Kammann H.
    J Dev Behav Pediatr; 2008 Apr 14; 29(2):106-16. PubMed ID: 18349709
    [Abstract] [Full Text] [Related]

  • 19. Social and communication behaviours in infants and toddlers with autism and pervasive developmental disorder-not otherwise specified.
    Fodstad JC, Matson JL, Hess J, Neal D.
    Dev Neurorehabil; 2009 Jun 14; 12(3):152-7. PubMed ID: 19466623
    [Abstract] [Full Text] [Related]

  • 20. Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism.
    Chadman KK.
    Pharmacol Biochem Behav; 2011 Jan 14; 97(3):586-94. PubMed ID: 20863848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.